title: Total lipid management and residual risk: beyond statin therapy.
abstract: Reducing cholesterol with statins has been clearly shown to reduce the risk of cardiovascular disease, but despite statin therapy there remains a considerable residual risk of cardiovascular disease. This article reviews the evidence supporting the management of lipids beyond cholesterol reduction with statin therapy alone.
authors.forename: Marc
authors.initials: M
authors.lastname: Evans
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects*; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D012307:Risk Factors; D040242:Risk Reduction Behavior
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids